Literature DB >> 15957997

The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilisation pregnancy.

Dong-Mok Lee1, Tae-Kyun Lee, Hai-Bum Song, Cheorl-Ho Kim.   

Abstract

OBJECTIVE: To investigate the role of matrix metalloproteinase-9 (MMP-9) in the pre-ovulatory follicular fluid and culture media during in vitro fertilisation (IVF) cycle and to develop the zymographic pre-diagnosis marker for successful implantation and pregnancy in human IVF.
DESIGN: Controlled clinical study.
SETTING: IVF Laboratory, Women's Hospital Infertility Clinic and Dongguk University, Korea. SAMPLE: Women undergoing in vitro fertilisation treatment.
METHODS: Experiments were designed for controlled clinical study with women undergoing IVF treatment. MMP-9 expressions in follicular fluid and culture media samples that had been collected during transvaginal oocyte retrieval were measured using zymography. MMP-9 activities and expressions were strongly correlated to a higher rate of fertilisation and pregnancy. MAIN OUTCOME MEASURES: Fertilisation rates and ultrasonic evidence of intrauterine pregnancy by four weeks after embryo transfer. RESULT: MMP-9 activity was significantly higher in the pregnant group than in the non-pregnant group (P < 0.01). In contrast, MMP-2 activity was present in the follicular fluid and culture media of all women, and no difference in its expressions was found between the pregnant and non-pregnant groups. No correlation was found between the MMP-9 expression in follicular fluid and culture media and the fertilisation rates.
CONCLUSION: The expression of MMP-9 in the follicular fluid and culture media is a prerequisite for successful pregnancy in IVF cycle. The zymography of MMP-9 activity in follicular fluids of human and culture media was developed as a pre-diagnostic method and zymographic diagnosis marker for successful fertilisation, implantation and pregnancy in human IVF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15957997     DOI: 10.1111/j.1471-0528.2005.00574.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

1.  Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization.

Authors:  Petra Horka; Karin Malickova; Radka Jarosova; Ivana Janatkova; Tomas Zima; Marta Kalousova
Journal:  J Assist Reprod Genet       Date:  2012-09-28       Impact factor: 3.412

Review 2.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Gene Polymorphism of Matrix Metalloproteinase 9 in Asthenozoospermic Male Subjects.

Authors:  Sina Mohagheghi; Iraj Khodadadi; Manoochehr Karami; Iraj Amiri; Heidar Tavilani
Journal:  Int J Fertil Steril       Date:  2017-10-12

4.  Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  Wen-Jui Yang; Fon-Chang Liu; Jih-Sheng Hsieh; Ching-Hung Chen; Shun-Yu Hsiao; Chih-Sheng Lin
Journal:  Reprod Biol Endocrinol       Date:  2015-09-04       Impact factor: 5.211

5.  Developmental consequences of supplementing with matrix metallopeptidase-9 during in vitro maturation of heat-stressed bovine oocytes.

Authors:  Megan R Goodwin; Louisa A Rispoli; Rebecca R Payton; Arnold M Saxton; J Lannett Edwards
Journal:  J Reprod Dev       Date:  2016-07-21       Impact factor: 2.214

6.  Activity of Matrix Metalloproteinase 2 and 9 in Follicular Fluid and Seminal Plasma and Its Relation to Embryo Quality and Fertilization Rate.

Authors:  Mojgan Atabakhsh; Iraj Khodadadi; Iraj Amiri; Hossain Mahjub; Heidar Tavilani
Journal:  J Reprod Infertil       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.